BioSpace News Archive

Humanigen, Inc. announced that its presentation time at the Jefferies London Healthcare Conference has been changed.

Erasca, Inc. today announced its participation in the Evercore ISI 4th Annual HealthCONx Conference. Jonathan E. Lim, M.D., chairman, CEO, and co-founder, and David M. Chacko, M.D., chief financial officer, will represent Erasca in a “Fireside Chat” beginning at 3:05 PM Eastern Time on Thursday, December 2, 2021.

Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, announced the pricing of an underwritten public offering of 25,000,000 shares of its common stock at a public offering price of $1.60 per share, for gross proceeds of $40.0 million to Optinose, before deducting underwriting discounts and before offering expenses.

Reflect Scientific, Inc. today announced financial results for the third quarter of 2021.

AIVITA Biomedical, Inc. today announced that chairman and CEO Dr. Hans S. Keirstead will deliver a keynote at the Vaccine World Asia Congress. The Singapore -based congress is being held virtually November 17-18 .

INOVIO (NASDAQ: INO), today announced that several volunteers have been dosed with its DNA-based, intradermal Ebola vaccine candidate, INO-4201, as part of a randomized, placebo-controlled, Phase 1b clinical trial (NCT04906629).

Canadian pharmacogenetic testing provider, Inagene Diagnostics Inc., has partnered with The Newly Institute, an advanced network of medically assisted psychotherapy clinics in Canada, specializing in outpatient programs for mental health, addiction and chronic pain.

DNA Script, a leader in Enzymatic DNA Synthesis, announced that Blanche Savary de Beauregard has joined the company as General Counsel.

CB Scientific. Inc. is pleased to announce that it has submitted its application to uplist to the OTCQB® Venture Market.

ImmunoGen Inc. today announced that Kristen Harrington-Smith has been appointed Senior Vice President and Chief Commercial Officer.